title: Lymphadenopathy in a patient with chronic myeloid leukaemia.
authors.affiliation: Hematology/Oncology Division, Henry Ford Hospital, Detroit, MI, USA. Yalkhat1@hfhs.org.
authors.forename: Yaser
authors.identifier: 0000-0002-8493-5035
authors.initials: Y
authors.lastname: Alkhatib
authors.affiliation: Hematology/Oncology Division, Henry Ford Hospital, Detroit, MI, USA.
authors.forename: Yue
authors.initials: Y
authors.lastname: Guo
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000069439:Dasatinib / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D060828:Induction Chemotherapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000628:therapy; D000072281:Lymphadenopathy / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D023981:Sarcoma, Myeloid / Q000175:diagnosis / Q000628:therapy; D033581:Stem Cell Transplantation / Q000379:methods
chemical_list: D000970:Antineoplastic Agents; D000069439:Dasatinib